Literature DB >> 18025514

Musculoskeletal infection: role of CT in the emergency department.

Laura M Fayad1, John A Carrino, Elliot K Fishman.   

Abstract

Musculoskeletal infection is commonly encountered in the emergency department and can take many forms, depending on the involvement of the various soft-tissue layers, bones, and joints. Infection may manifest as superficial cellulitis, necrotizing or nonnecrotizing fasciitis, myositis, a soft-tissue abscess, osteomyelitis, or septic arthritis. Because clinical parameters for the detection of musculoskeletal infection generally lack sensitivity and specificity, computed tomography (CT) plays an important role in the assessment of potential musculoskeletal infections in the emergency department. CT provides an analysis of compartmental anatomy, thereby helping to distinguish among the various types of musculoskeletal infection and to guide treatment options. Specific imaging features exist that help identify the numerous forms of infection in the bones and soft tissues, and CT is invaluable for detecting deep complications of cellulitis and pinpointing the anatomic compartment that is involved by an infection. Although all patients with musculoskeletal infection will require treatment with antibiotics, CT helps guide therapy toward emergency surgical débridement in cases of necrotizing fasciitis and toward percutaneous drainage in cases of abscess formation. RSNA, 2007

Entities:  

Mesh:

Year:  2007        PMID: 18025514     DOI: 10.1148/rg.276075033

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  32 in total

1.  MR imaging of skeletal soft tissue infection: utility of diffusion-weighted imaging in detecting abscess formation.

Authors:  Srinivasan Harish; Mary M Chiavaras; Nikhil Kotnis; Ryan Rebello
Journal:  Skeletal Radiol       Date:  2010-06-16       Impact factor: 2.199

2.  The role of contrast enhanced computed tomography in the diagnosis of necrotizing fasciitis and comparison with the laboratory risk indicator for necrotizing fasciitis (LRINEC).

Authors:  Francesco Carbonetti; Antonio Cremona; Valentina Carusi; Marco Guidi; Elsa Iannicelli; Marco Di Girolamo; Daniela Sergi; Alvise Clarioni; Giulio Baio; Giulio Antonelli; Luca Fratini; Vincenzo David
Journal:  Radiol Med       Date:  2015-08-19       Impact factor: 3.469

Review 3.  MR imaging of urgent inflammatory and infectious conditions affecting the soft tissues of the musculoskeletal system.

Authors:  Joseph S Yu; Paula Habib
Journal:  Emerg Radiol       Date:  2009-01-09

Review 4.  CT of the skin and subcutaneous tissues.

Authors:  Douglas S Katz; George Ganson; Michelle A Klein; Joseph P Mazzie
Journal:  Emerg Radiol       Date:  2012-09-26

5.  Diagnosis of infection in the diabetic foot using (18)F-FDG PET/CT: a sweet alternative?

Authors:  Gopinath Gnanasegaran; Sanjay Vijayanathan; Ignac Fogelman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10       Impact factor: 9.236

Review 6.  Necrotizing fasciitis: an urgent diagnosis.

Authors:  Silvia Paz Maya; Delfina Dualde Beltrán; Pierre Lemercier; Carlos Leiva-Salinas
Journal:  Skeletal Radiol       Date:  2014-01-29       Impact factor: 2.199

Review 7.  MDCT of the hand and wrist: beyond trauma.

Authors:  Shivani Ahlawat; Frank M Corl; Elliot K Fishman; Laura M Fayad
Journal:  Emerg Radiol       Date:  2014-10-10

8.  CT in necrotizing soft tissue infection: diagnostic criteria and comparison with LRINEC score.

Authors:  Rik J M Bruls; Robert M Kwee
Journal:  Eur Radiol       Date:  2021-05-04       Impact factor: 5.315

Review 9.  MRI in necrotizing fasciitis of the extremities.

Authors:  S Z Ali; S Srinivasan; W C G Peh
Journal:  Br J Radiol       Date:  2013-11-28       Impact factor: 3.039

10.  Comparison of characteristic CT findings of lymphedema, cellulitis, and generalized edema in lower leg swelling.

Authors:  Sung Ui Shin; Whal Lee; Eun-Ah Park; Cheong-Il Shin; Jin Wook Chung; Jae Hyung Park
Journal:  Int J Cardiovasc Imaging       Date:  2013-11-30       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.